IRIS
Valenti, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 618
AS - Asia 303
EU - Europa 237
AF - Africa 21
OC - Oceania 1
SA - Sud America 1
Totale 1.181
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 612
CN - Cina 183
SG - Singapore 101
IE - Irlanda 49
FI - Finlandia 45
IT - Italia 36
FR - Francia 28
NG - Nigeria 19
DE - Germania 15
BE - Belgio 12
GB - Regno Unito 10
SE - Svezia 10
IN - India 7
NL - Olanda 7
RU - Federazione Russa 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
JP - Giappone 4
HK - Hong Kong 3
MX - Messico 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
CA - Canada 2
MT - Malta 2
TR - Turchia 2
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
IM - Isola di Man 1
KR - Corea 1
KW - Kuwait 1
LK - Sri Lanka 1
MA - Marocco 1
PL - Polonia 1
RS - Serbia 1
TN - Tunisia 1
Totale 1.181
Salva come PNG Salva come JPEG
Città #
Shanghai 165
Chandler 150
Singapore 75
Boardman 70
Dublin 49
Helsinki 45
New York 42
Wilmington 24
San Mateo 23
Lawrence 22
Princeton 22
Ashburn 21
Benin City 19
Paris 13
Los Angeles 12
Milan 12
Brussels 11
Seattle 10
Ann Arbor 9
Dallas 9
Duncan 7
Phoenix 7
Amsterdam 6
London 6
Munich 6
Santa Clara 5
Brno 4
Esbjerg 4
Moscow 4
Tokyo 4
Aguascalientes 3
Bergamo 3
Bratislava 3
Catania 3
Fairfield 3
Hong Kong 3
Leawood 3
Pavia 3
Chengdu 2
Falkenstein 2
Kochi 2
Ludhiana 2
Nancy 2
Naples 2
Ottawa 2
Pune 2
Slough 2
Thyez 2
Andover 1
Belgrade 1
Berlin 1
Bollebygd 1
Chicago 1
Colombo 1
Douglas 1
Dundee 1
Florence 1
Fort Worth 1
Fulham 1
Harbin 1
Kocaeli 1
Kuwait City 1
Longueville 1
Nanchang 1
New Delhi 1
Newark 1
Norwalk 1
Novokuznetsk 1
Oakland 1
Padova 1
Rabat 1
Redmond 1
Rome 1
Sale Marasino 1
San Diego 1
Shenyang 1
Siziano 1
Springfield 1
Taiyuan 1
Tunis 1
Venlo 1
Xi'an 1
Zhongshan 1
Totale 935
Salva come PNG Salva come JPEG
Nome #
Rosacea-like Acute Reaction After Hyaluronic Acid Dermal Filler 83
Brodalumab: a new way to inhibit IL-17 in psoriasis 61
Specific Infiltrate of Hodgkin Lymphoma at Site of Cellulitis Mimicking Secondary Cutaneous Involvement 59
A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever 46
Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population 44
Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative study 41
Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab 38
Palmar nodules in a young woman with ulcerative colitis and enteropathic arthritis 36
Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study 35
Apremilast for the treatment of palmo-plantar non-pustular psoriasis: A real-life single-center retrospective study 35
Reorganization of a Northern Italy dermatology department during the COVID-19 pandemic: is it temporary or the beginning of a new era in dermatology? 34
Concomitant Pyoderma Gangrenosum-like and Amicrobial Pustulosis of the Folds: a Case Report 34
Effects of TNF-α inhibition on pre-clinical enthesitis: observational study on 49 psoriatic patients 34
Impact of delay in follow-up due to COVID-19 pandemic on skin cancer progression: a real-life experience from an Italian hub hospital 33
Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab 33
Urticarial rash in autoinflammatory syndromes 32
Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab 30
Pregnancy outcome of a patient treated with upadacitinib for severe atopic dermatitis 19
Multiple facial angiofibromas: A manifestation of Frank-ter Haar syndrome? 19
Cutaneous toxicity of CAR T-cell therapy: Case report of a bullous life-threatening reaction 17
Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective study 16
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study 14
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 14
Bullous vasculitis associated with Streptococcus pyogenes sepsis 13
Skin cancers: how to balance the risks and benefits of surgery during COVID-19 pandemic (a Northern Italy single-center experience) 13
Effectiveness and safety of anti-IL-23 and anti-IL-17 biological therapies for psoriasis in elderly patients: Real-world experience from two Italian hospitals 13
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 13
Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study 12
Long-Term Sequential Digital Dermoscopy of Low-Risk Patients May Not Improve Early Diagnosis of Melanoma Compared to Periodical Handheld Dermoscopy 12
Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience 12
Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study 12
Real-life efficacy of guselkumab in patients with early psoriatic arthritis 12
Connective tissue panniculitis and vitiligo in a patient with stage IV melanoma achieving complete response to dabrafenib and trametinib combination therapy 12
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks 11
Pembrolizumab-induced plaque psoriasis successfully treated with risankizumab in a patient with stage IV cutaneous melanoma 11
Early predictors of psoriatic arthritis: a delphi based consensus from Italian dermatology centers 11
Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience 10
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS) 10
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis) 10
Sub-erythrodermic psoriasis successfully treated with bimekizumab: A case report 10
Efficacy and safety of switching psoriatic patients to bimekizumab: new evidence from clinical trials 10
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study 9
Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab 9
Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study 9
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 8
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis) 8
Risk of peripheral neuropathy in patients with psoriasis and psoriatic arthritis. A prospective cohort study 8
Effectiveness and safety of upadacitinib for moderate‐to‐severe atopic dermatitis in a real‐world setting: A 52‐week retrospective study 8
A severe case of IgA bullous pemphigoid successfully treated with dupilumab 8
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers 8
Upadacitinib for the treatment of atopic dermatitis in the elderly: an Italian case series of seven patients 8
Intra-Class Switch Among IL-23 Inhibitors for Plaque Psoriasis: Is It Worth It? 8
What Can IBD Specialists Learn from IL-23 Trials in Dermatology? 8
Risankizumab for the treatment of genital psoriasis: A 1-year, real-world experience 7
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case‐series 7
Nonadherence to immune-modifying therapies during the COVID-19 pandemic: the crucial role of doctor-patient communication in avoiding drug discontinuation 7
Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options 7
New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series 7
Apremilast for the treatment of pustular psoriasis induced by neoadjuvant ifosfamide + etoposide chemotherapy for Ewing Sarcoma: a case report 7
Long-term management of pediatric psoriasis with ixekizumab: a case report 7
Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience 6
Combination intravenous immunoglobulin, oral prednisone, and methotrexate for managing scleromyxedema: case report and literature discussion 6
Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective Study 6
Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study 6
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis) 6
Arrhythmias and other cardiovascular diseases in young patients (<40 years) with moderate/severe atopic dermatitis: A multicentric study in northern Italy 6
Atypical facial pustular folliculitis by Klebsiella pneumoniae: a case report 6
The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV-2 infection and vaccination 5
Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021 4
Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals 4
Effectiveness of ixekizumab for the treatment of moderate‐to‐severe plaque psoriasis with involvement of difficult‐to‐treat areas: A 52‐week multicenter retrospective study 4
Upadacitinib 30 mg for the optimal management of moderate-to-severe atopic dermatitis: a 52-week single-center real-world study 4
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real‐life Italian multicenter observational study of 250 patients 3
Topical Pharmacological Treatment of Actinic Keratoses: Focus on Tirbanibulin 1% Ointment 3
Geometric contour variation in clinical target volume of axillary lymph nodes in breast cancer radiotherapy: an AIRO multi-institutional study 3
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel 3
Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review 3
Methotrexate-Induced Mucositis in a Patient With Angioimmunoblastic T-cell Lymphoma 3
Real-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center Study 3
Thin Amelanotic and Hypomelanotic Melanoma: Clinicopathological and Dermoscopic Features 3
Safety of Interleukin Inhibitors in Patients with Plaque Psoriasis and Neoplasm: A Retrospective Study from Two Referral Centers 3
Melanoma in Adolescents and Young Adults (AYAs): An Italian Multi-Centric Retrospective Experience 2
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 2
Anorectal melanoma: systematic review of the current literature of an aggressive type of melanoma 2
A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis—IL PSO (Italian Landscape Psoriasis) 2
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study 2
Long-term effectiveness and safety of risankizumab in patients with moderate-to-severe psoriasis with and without cardiometabolic comorbidities: a single-center retrospective study 1
Noninvasive Assessment and Management of Folliculitis Decalvans by Trichoscopy and Reflectance Confocal Microscopy 1
Totale 1.264
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.523
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 2 0 0 0 8 6 8 13 7 1 11
2021/2022110 1 0 3 13 2 3 5 10 26 8 32 7
2022/2023359 55 28 25 58 33 27 0 29 55 29 20 0
2023/2024528 16 37 98 28 11 49 59 45 12 22 52 99
2024/2025211 13 35 14 19 5 105 20 0 0 0 0 0
Totale 1.264